Deepinder Goyal calls Temple criticism 'funny', device not for sale yet

• Deepinder Goyal responded to criticism regarding Temple, an experimental health-tech wearable.
• He stated the device is not commercially available, has not been marketed, and scientific discussions are premature.
• Goyal called the criticism "funny" as the product isn't available for purchase or pre-order.
• Temple is a research prototype designed to continuously measure blood flow to the brain, linked to Goyal's "Gravity Ageing Hypothesis."
• Medical experts, like Dr. Datta from AIIMS Delhi, have questioned the device's scientific validity, calling it "pseudoscientific."

Why It Matters: Deepinder Goyal dismisses early criticism of his experimental health-tech wearable, Temple, as premature.